exploring the roles of mscs in infections: focus on bacterial diseases

Despite human healthcare advances, some microorganisms continuously react evolving new survival strategies, choosing between a commensal fitness and a pathogenic attitude. many opportunistic microbes are becoming an increasing cause of clinically evident infections while several renowned infectious diseases sustain a considerable number of deaths. besides the primary and extensively investigated role of immune cells, other cell types are involved in the microbe-host interaction during infection. interestingly, mesenchymal stem cells (mscs), the current leading players in cell therapy approaches, have been suggested to contribute to tackling pathogens and modulating the host immune response. in this context, this review critically explores mscs’ role in e. coli, s. aureus, and polymicrobial infections. summarizing from various studies, in vitro and in vivo results support the mechanistic involvement of mscs and their derivatives in fighting infection and in contributing to microbial spreading. our work outlines the double face of mscs during infection, disease, and sepsis, highlighting potential pitfalls in msc-based therapy due to the mscs’ susceptibility to pathogens’ weapons. we also identify potential targets to improve infection treatments, and propose the potential applications of mscs for vaccine research.